We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
+24.92%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$126M
AUM Growth
+$9.73M
Cap. Flow
-$2.73M
Cap. Flow %
-2.16%
Top 10 Hldgs %
37.67%
Holding
493
New
153
Increased
113
Reduced
67
Closed
127

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$3.82M
2
BMY icon
Bristol-Myers Squibb
BMY
+$2.47M
3
IBB icon
iShares Biotechnology ETF
IBB
+$2M
4
ULTA icon
Ulta Beauty
ULTA
+$1.86M
5
MON
Monsanto Co
MON
+$1.82M

Top Sells

Rank Stock Value
1
MDVN
MEDIVATION, INC.
MDVN
+$7.18M
2
BIIB icon
Biogen
BIIB
+$4.33M
3
CALM icon
Cal-Maine
CALM
+$3.64M
4
AAPL icon
Apple
AAPL
+$2.74M
5
ALR
Alere Inc
ALR
+$2.22M

Sector Composition

Rank Sector Weight
1 Healthcare 42.49%
2 Miscellaneous 37.27%
3 Consumer Staples 5.72%
4 Consumer Discretionary 5.23%
5 Technology 3.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRTX icon
51
Vertex Pharmaceuticals
VRTX
$138B
$584K 0.46%
+6,694
New +$633K
HRTX icon
52
Heron Therapeutics
HRTX
$65.3M
$516K 0.41%
29,937
+24,781
+481% +$460K
HD icon
53
Home Depot
HD
$320B
$515K 0.41%
4,000
+500
+14% +$66.6K
SCYX icon
54
SCYNEXIS
SCYX
$52.7M
$506K 0.4%
1,634
-315
-16% -$66.5K
SPLK
55
DELISTED
Splunk Inc
SPLK
$466K 0.37%
7,940
-1,287
-14% -$77.1K
PTCT icon
56
CALL
PTC Therapeutics
PTCT
$5.78B
$451K 0.36%
100,400
+10,000
+11% +$81.3K
MSFT icon
57
Microsoft
MSFT
$3.71T
$441K 0.35%
7,657
-5,688
-43% -$321K
DELL icon
58
Dell
DELL
$339B
$440K 0.35%
+32,817
New +$446K
LRMR icon
59
Larimar Therapeutics
LRMR
$398M
$437K 0.35%
10,994
+8,916
+429% +$405K
BABA icon
60
Alibaba
BABA
$281B
$434K 0.34%
4,100
+2,900
+242% +$269K
VRTX icon
61
PUT
Vertex Pharmaceuticals
VRTX
$138B
$429K 0.34%
+12,300
New +$1.16M
ESPR
62
CALL
DELISTED
Esperion Therapeutics
ESPR
$421K 0.33%
110,600
+25,100
+29% +$284K
ISEE
63
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$417K 0.33%
55,100
+43,800
+388% +$2.47M
NBRV
64
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$414K 0.33%
232
+34
+17% +$65.6K
TSRO
65
DELISTED
TESARO, Inc.
TSRO
$405K 0.32%
4,045
-2,963
-42% -$277K
GIS icon
66
PUT
General Mills
GIS
$20.5B
$393K 0.31%
68,600
+48,600
+243% +$3.38M
UTHR icon
67
PUT
United Therapeutics
UTHR
$20.9B
$385K 0.31%
+21,000
New +$2.52M
CYBR
68
DELISTED
CyberArk
CYBR
$362K 0.29%
+7,300
New +$389K
GWPH
69
PUT
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$362K 0.29%
78,900
+33,400
+73% +$3.19M
ITCI
70
PUT
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$359K 0.28%
+18,000
New +$728K
CHTR icon
71
Charter Communications
CHTR
$18.1B
$355K 0.28%
1,315
+240
+22% +$60.6K
ISEE
72
PUT
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$355K 0.28%
17,000
+5,000
+42% +$282K
YUM icon
73
CALL
Yum! Brands
YUM
$41.1B
$352K 0.28%
66,073
+27,820
+73% +$1.78M
KLAC icon
74
KLA
KLAC
$242B
$350K 0.28%
50,170
+33,000
+192% +$238K
MNK
75
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$349K 0.28%
+5,004
New +$362K
1 2
3
4 5

Similar funds

MC
Micawber Capital Seattle, Washington $62.9M AUM 20.32% 1-Year Est. Return
FIM
Friedberg Investment Management Houston, Texas $61.9M AUM 20.07% 1-Year Est. Return
TLIC
Thai Life Insurance Company Bangkok, Thailand $71M AUM 20.14% 1-Year Est. Return
MKCM
Mount Kellett Capital Management New York $61M AUM 12.22% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
MFM
Marianas Fund Management New York $58.1M AUM 10.84% 1-Year Est. Return
VE
Vega Energy New York $75.5M AUM 15.36% 1-Year Est. Return
GFWEV
G.F.W. Energy VIII Irving, Texas $76.3M AUM 11.41% 1-Year Est. Return

FT Options's Q3 2016 Portfolio in Review

As of Q3 2016, FT Options held 493 positions worth $126M, up 8.4% from $116M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

FT Options's Q3 2016 filing shows 153 new, 113 increased, 67 reduced and 127 closed positions. Its largest new stake was iShares Biotechnology ETF: 21,000 shares worth $2.03M. The largest sale was MEDIVATION, INC., an estimated $7.18M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 41% a quarter earlier, followed by Miscellaneous and Consumer Staples.

  • FT Options's largest Q3 2016 buy was iShares Biotechnology ETF: 21,000 shares worth $2.03M.
  • FT Options added most to Procter & Gamble in Q3 2016, an estimated $3.82M increase.
  • FT Options's biggest Q3 2016 reduction was Apple, cutting an estimated $2.74M.
  • FT Options fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $7.18M.
  • FT Options's ten largest holdings make up 38% of its $126M portfolio in Q3 2016.
  • FT Options opened 153 new positions and closed 127 in Q3 2016.
  • FT Options's portfolio value rose 8.4% quarter-over-quarter to $126M.

Based on FT Options's 13F filing for Q3 2016, filed 10 Nov 2016.